Imatinib D4 is the tetra-deuterated form of Imatinib (STI571), Imatinib (Gleevec or Glivec) is an orally bioavailable multi-kinase inhibitor of v-Abl, c-Kit and PDGFR approved for cancer treatment (e.g. a number of leukemias).

纯度：≥98%

CAS：1134803-16-9